AURITEC PHARMACEUTICALS INC

Basic Information

2285 FOODHILL BLVD
PASADENA, CA, 91107-3658

Company Profile

n/a

Additional Details

Field Value
DUNS: 148679884
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 11


  1. Clinical safety and pharmacokinetic studies of intravaginal rings releasing multiple antiretrovirals

    Amount: $664,015.00

    DESCRIPTION provided by applicant The goal of this project is to prevent HIV transmission Using the drug delivery platform that we developed for the ganciclovir intraocular implant Vitrasert r ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. Automation of GMP manufacturing of HIV microbicide rings

    Amount: $337,439.00

    DESCRIPTION provided by applicant The broad long term goal of this work is to empower women in the developing world to protect themselves against HIV infection through the use of an HIV microbicide ...

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  3. An intravaginal ring for real-time evaluation of adherence to topical vagina

    Amount: $211,862.00

    DESCRIPTION (provided by applicant): The broad long-term of this project is to develop methods for evaluation of adherence to intravaginal microbicide therapy for the prevention of HIV transmission. C ...

    STTR Phase I 2013 Department of Health and Human Services
  4. A Flow Through Cell Counting Assay

    Amount: $338,981.00

    DESCRIPTION (provided by applicant): The long term goal of this project is to prevent HIV transmission. Using the drug delivery platform we developed for the ganciclovir intraocular implant, Vitrasert ...

    SBIR Phase I 2013 Department of Health and Human Services
  5. Depot intra-articular fluticasone for the treatment of arthritis

    Amount: $1,191,901.00

    DESCRIPTION (provided by applicant): The broad long-term goal of this research is to reduce morbidity due to arthritis by developing long-lasting injectable intra-articular drug delivery systems. Intr ...

    SBIR Phase II 2013 Department of Health and Human Services
  6. Intravaginal ring delivery of tenofovir and emtricitabine

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): The long term goal of this project is to prevent HIV transmission. Using the drug delivery platform we developed for the ganciclovir intraocular implant, the Vitra ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. Sustained Release intravitreal VEGFR inhibition to prevent blindness

    Amount: $296,405.00

    DESCRIPTION (provided by applicant): The broad long term goal of this project is to develop an improved treatment for neovascular age-related macular degeneration and for diabetic retinopathy: the two ...

    SBIR Phase I 2012 Department of Health and Human Services
  8. Preclinical development of a tenofovir intravaginal ring for HIV prophylaxis

    Amount: $2,993,089.00

    DESCRIPTION (provided by applicant): Large efforts are currently underway funded by the NIH, the Gates foundation, and the WHO, to reduce the spread of HIV transmission by developing an effective micr ...

    SBIR Phase II 2011 Department of Health and Human Services
  9. Sustained Release Depot Olanzapine

    Amount: $1,073,890.00

    DESCRIPTION (provided by applicant): The long-term goal of this research is to minimize morbidity due to non-adherence to outpatient antipsychotic-antimanic therapy with olanzapine. Olanzapine is curr ...

    SBIR Phase II 2010 Department of Health and Human Services
  10. Depot calcineurin inhibitors to prevent graft rejection

    Amount: $1,330,820.00

    DESCRIPTION (provided by applicant): The long term goal of this research is to reduce toxicity and graft rejection due to dosing problems with the calcineurin inhibitors by developing a sustained rele ...

    SBIR Phase II 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government